Skip to main content

Table 1 Study hospitals, their catchment populations, available treatments and respective approximate patient out-of-pocket costs during the study period

From: Inequities in breast cancer treatment in sub-Saharan Africa: findings from a prospective multi-country observational study

Country Namibia Nigeria Uganda
Site Public: AB May Cancer Care Centre, Windhoek Central Hospital Public: Federal Medical Centre Owerri and Abia State University Teaching Hospital; Private: Marantha clinic, Aba Public: Mulago Hospital and Uganda Cancer Institute, Kampala
Catchment population National Federal National
ABC-DO participants* 104 non-black and 398 black women 313 public, 80 private patients 430
Medical treatment: approximate patient out-of-pocket costs in USD, at time of study
  Mammography (diagnostic) Free 22 30
  Computer tomography Free 145 100
  BiopsyA Free 85 10
  Fine-needle aspiration cytology (FNAC)A Free 6 10
  Immunohistochemistry (IHC)AB Free Not available 70
  Full blood tests Free 40 5
  ECG Free 90 20
  Mastectomy Free 250 Free
  Pre-chemotherapy tests Free No information 50–400
  Chemotherapy per cycle Free 65–1500 120–200
 Hormone drugs/month
  Tamoxifen Free 40 10–20
  Anastrazole Free 20 50–60
  Herceptin Free 1100 3000
  Radiotherapyc Free Nearest public radiotherapy facility is 150 km away from Enugu Freec
  1. *Numbers refer to excluded women without any treatment data (n = 7)
  2. ASpecimens were taken for all women in Namibia and 94% and 59% of Ugandan and Nigerian patients, respectively. Most specimens were core biopsies (74%), followed by excisional biopsies (14%) and Fine Needle Aspiration Cytology (FNAC) (11%). IHC was performed for 96% of Namibian women, but only 10% and 9% of Ugandan and Nigerian women, respectively
  3. BPrices are for determination of full receptor status (endocrine, progesterone and human epidermal growth factor receptor 2)
  4. cRadiotherapy was not available in Uganda from March 2016 for 1.5 years